NEW YORK (GenomeWeb News) – BD Diagnostics said today that the US Food and Drug Administration has cleared the BD ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay to run on BD's Viper System with XTR Technology.

The assay is for the qualitative detection of T. vaginalis DNA in endocervical and vaginal samples, as well as neat urine samples, to aid in the diagnosis of trichomoniasis. The assay is also CE-IVD marked.

BD Diagnostics, a segment of Becton Dickinson, today also launched the product.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.